CJC-1295 (without DAC) and MOTS-c Interaction

Synergistic
Mechanism-based 51% confidence

CJC-1295 (without DAC) and MOTS-c have a synergistic interaction with 51% confidence. CJC-1295 (without DAC) helps counteract the insulin-disrupting effects of MOTS-c. A smart combination — the insulin sensitizer mitigates metabolic side effects. These compounds primarily affect different organ systems.

Compound Profiles

CJC-1295 (without DAC)

Short-Acting Growth Hormone Releasing Hormone Analog

Binds GHRH receptors on somatotroph cells in the pituitary gland, stimulating cAMP production and physiological GH pulses. The brief 30-minute half-life allows pulsatile release versus prolonged elevation.

Half-life: 30 minutes - 2 hours Typical dose: 100-300mcg per injection growth hormone, weight loss
ghrh receptor carcinogenic riskestrogenicinsulin disruptingteratogenic
View full profile

MOTS-c

Mitochondrial-Derived Peptide | Metabolic Regulator

Inhibits the folate cycle leading to AMPK activation. Under metabolic stress, translocates to nucleus to bind stress-response transcription factors, regulating genes involved in metabolism, insulin sensitivity, and cellular adaptation.

Half-life: ~30 minutes Typical dose: Start 5mg daily, increase to 10-15mg based on goals longevity, metabolic
ampknrf2 insulin disruptinginsulin sensitizingteratogenic
View full profile

Combined Organ Load

GI Tract
low
Pituitary
low
Pancreas
low

Shared Safety Flags

2x 2 compounds affect insulin sensitivity (CJC-1295 (without DAC), MOTS-c). Monitor fasting glucose and HbA1c.
2x 2 compounds share the teratogenic safety flag (CJC-1295 (without DAC), MOTS-c). Monitor accordingly.

Frequently Asked Questions

Can I take CJC-1295 (without DAC) with MOTS-c?

Yes, CJC-1295 (without DAC) and MOTS-c can generally be taken together. CJC-1295 (without DAC) helps counteract the insulin-disrupting effects of MOTS-c. A smart combination — the insulin sensitizer mitigates metabolic side effects.

Is CJC-1295 (without DAC) and MOTS-c safe together?

Based on pharmacological analysis, this combination is considered synergistic. However, shared safety flags include: insulin disrupting, teratogenic. Monitor accordingly.

What are the interactions between CJC-1295 (without DAC) and MOTS-c?

CJC-1295 (without DAC) helps counteract the insulin-disrupting effects of MOTS-c. A smart combination — the insulin sensitizer mitigates metabolic side effects. This assessment has 51% confidence and is inferred from pharmacological mechanism analysis.

How should I time CJC-1295 (without DAC) and MOTS-c?

CJC-1295 (without DAC) has a half-life of 30 minutes - 2 hours and MOTS-c has a half-life of ~30 minutes. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: CJC-1295 (without DAC) vs MOTS-c

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.